Anzeige
Mehr »
Dienstag, 16.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14W4W | ISIN: SE0007577895 | Ticker-Symbol: 6Y4
Tradegate
15.09.25 | 07:30
0,986 Euro
-0,70 % -0,007
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
VICORE PHARMA HOLDING AB Chart 1 Jahr
5-Tage-Chart
VICORE PHARMA HOLDING AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,9030,92323:00
0,9210,92221:32

Aktuelle News zur VICORE PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoVicore Pharma Holding: Vicore to Present at Pareto Securities' 16th Annual Healthcare Conference168STOCKHOLM, SE / ACCESS Newswire / September 15, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today...
► Artikel lesen
28.08.Vicore Pharma Holding: Vicore to Present at Upcoming Investor Conferences210STOCKHOLM, SE / ACCESS Newswire / August 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced...
► Artikel lesen
22.08.Vicore Pharma Holding: Interim Report April - June 2025321STOCKHOLM, SE / ACCESS Newswire / August 22, 2025 / Vicore Pharma Holding AB (STO: VICO) ("Vicore"), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs)...
► Artikel lesen
VICORE PHARMA Aktie jetzt für 0€ handeln
30.06.Vicore Pharma Holding: Increase in Number of Shares and Votes in Vicore Pharma328STOCKHOLM, SE / ACCESS Newswire / June 30, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists...
► Artikel lesen
28.05.Vicore Pharma Holding: Vicore to Present at the Jefferies Global Healthcare Conference273STOCKHOLM, SE / ACCESS Newswire / May 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced...
► Artikel lesen
22.05.Vicore Pharma Holding: Vicore Presents New Data at the 2025 American Thoracic Society International Conference590STOCKHOLM, SE / ACCESS Newswire / May 22, 2025 / Vicore Pharma Holding (STO:VICO) - Stockholm, May 22, 2025 - Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs,...
► Artikel lesen
06.05.Bulletin from the Annual General Meeting of Vicore Pharma Holding AB378STOCKHOLM, SE / ACCESS Newswire / May 6, 2025 / Vicore Pharma Holding (STO:VICO) - The following resolutions were passed at the annual general meeting (the "AGM") of Vicore Pharma Holding AB (publ)...
► Artikel lesen
06.05.Vicore Pharma Holding: Interim Report January - March 2025473STOCKHOLM, SE / ACCESS Newswire / May 6, 2025 / Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs)...
► Artikel lesen
02.05.Vicore Pharma Holding: Vicore to Present at the Nordea Equities Healthcare Seminar620STOCKHOLM, SE / ACCESS Newswire / May 2, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced...
► Artikel lesen
23.04.Vicore Pharma Holding: Vicore Announces Presentations at the 2025 American Thoracic Society International Conference353STOCKHOLM, SE / ACCESS Newswire / April 23, 2025 / Vicore Pharma Holding (STO:VICO)Stockholm, April 23, 2025 - Vicore Pharma Holding AB (STO: VICO), unlocking the potential of a novel class of drugs...
► Artikel lesen
28.03.Vicore Pharma Holding: Vicore to Participate in the Van Lanschot Kempen Life Sciences Conference1.090STOCKHOLM, SE / ACCESS Newswire / March 28, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced...
► Artikel lesen
26.03.Notice of Annual General Meeting of Vicore Pharma Holding AB332STOCKHOLM, SE / ACCESS Newswire / March 26, 2025 / Vicore Pharma Holding (STO:VICO)The shareholders of Vicore Pharma Holding AB (publ), Reg. No. 556680-3804 ("Vicore Pharma" or the "company"), with...
► Artikel lesen
26.03.Vicore Pharma Holding: Vicore Publishes the Annual Report for 2024337STOCKHOLM, SE / ACCESS Newswire / March 26, 2025 / Vicore Pharma Holding (STO:VICO) Stockholm, March 26, 2025 - Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs...
► Artikel lesen
27.02.Vicore Pharma Holding Year-End Report 2024393STOCKHOLM, SWEDEN / ACCESS Newswire / February 27, 2025 / Vicore Pharma Holding (STO:VICO) Stockholm, February 27, 2025 - Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a...
► Artikel lesen
26.02.Vicore Pharma Holding: Vicore to Present at Upcoming Investor Conferences326STOCKHOLM, SWEDEN / ACCESS Newswire / February 26, 2025 / Vicore Pharma Holding (STO:VICO) Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type...
► Artikel lesen
19.09.24Nasdaq Stockholm AB: Listing of subscription rights and Paid subscription shares of Vicore Pharma Holding AB669With effect from September 20, 2024, the subscription rights of Vicore Pharma Holding AB will be traded on the list for Equity rights. Trading will continue up until and including October 01, 2024....
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1